- Home
- RYTM vs MASI Comparison
RYTM vs MASI Comparison
Compare RYTM & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RYTM | MASI |
|---|---|---|
| Founded | 2008 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.0B |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RYTM | MASI |
|---|---|---|
| Price | $86.84 | $175.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 6 |
| Target Price | $129.93 | ★ $184.25 |
| AVG Volume (30 Days) | 709.0K | ★ 2.4M |
| Earning Date | 05-25-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.34 | ★ 51.05 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,239,153,000.00 |
| Revenue This Year | $57.46 | $8.59 |
| Revenue Next Year | $85.60 | $7.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.34 |
| 52 Week Low | $45.91 | $125.94 |
| 52 Week High | $122.20 | $175.90 |
Technical Indicators
Market Signals| Indicator | RYTM | MASI |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 75.47 |
| Support Level | $85.59 | $157.54 |
| Resistance Level | $96.92 | $175.90 |
| Average True Range (ATR) | 5.11 | 0.33 |
| MACD | -0.45 | -1.02 |
| Stochastic Oscillator | 21.76 | 52.50 |
Price Performance
Historical ComparisonAbout RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About MASI Masimo Corporation
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.